United Therapeutics diskutieren
United Therapeutics
WKN: 923818 / Symbol: UTHR / Name: Utd Therapeut / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
269,10 €
0,49 %
United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Morgan Stanley from $316.00 to $318.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $308.00 price target on the stock, up previously from $307.00.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $309.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $330.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $308.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Wells Fargo & Company from $309.00 to $325.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Oppenheimer Holdings Inc. from $375.00 to $400.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $300.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Wells Fargo & Company from $325.00 to $350.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Pacific Gas & Electric Comp. diskutieren